Skip to Main Content
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

Jennifer Ellen Miller, PhD

Associate Professor of Medicine (General Medicine); Director, Good Pharma Scorecard; Board President, Bioethics International; Advisory Board Member, Global Healthcare Innovation Management Center, Graduate School of Business; Yale Liaison, Working Group on: Bioethics of Data Science, Artificial Intelligence (AI) and Genomics Implementation Science Curriculum; Expanded Access Program for Experimental Covid19 Drugs, Ethics Committee

Contact Information

Jennifer Ellen Miller, PhD

Mailing Address

  • Yale School of Medicine

    367 Cedar Street, Harkness 4th floor

    New Haven, CT 06520

    United States

DownloadHi-Res Photo

Appointments

Biography

Jennifer E. Miller, PhD, is an Associate Professor in Yale School of Medicine; Director of the Good Pharma Scorecard (an index that ranks pharmaceutical companies on their bioethical performance); and Founder of the nonprofit Bioethics International. 

Her current research focuses on ethics, equity and governance in drug, vaccine and medical device research, development, and delivery as well as in healthcare data sharing. She also specializes in developing and using metrics to enhance accountability and social responsibility in biomedical innovation. 

Prior to joining Yale’s faculty, she was an Assistant Professor (tenure track) in NYU School of Medicine and completed training in physics, regulatory governance, bioethics, and ethics at Fordham University, Duke University, Regina Apostolorum Pontifical University, and Harvard University. 

Education & Training

  • Non Degree Program
    Harvard University, Ethics (2015)
  • Postdoctoral Fellowship
    Duke University (2015)
  • PhD
    Regina Apostolorum Pontifical University, Bioethics (2015)
  • Postdoctoral Fellowship
    Harvard University (2014)
  • BS
    Fordham University, Physics (2002)

Activities

  • Pharmaceutical Industry Ethics and The Good Pharma Scorecard
    New York, NY, United States 2020
    Pharmaceutical Industry Ethics and The Good Pharma Scorecard
  • What Makes Medical Data Sharing Ethical?
    New York, NY, United States 2020
    What Makes Medical Data Sharing Ethical?
  • Clinical Trial Transparency and Data Sharing
    Broadstairs, England, United Kingdom 2020
    Clinical Trial Transparency and Data Sharing
  • Panel on Genomic Medicine Ethics
    San Diego, CA, United States 2020
    Panel on Genomic Medicine Ethics
  • EHR Data Sharing: What Makes Data Sharing Ethical?
    Philadelphia, PA, United States 2020
    EHR Data Sharing: What Makes Data Sharing Ethical?
  • Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma Scorecard
    Ottawa, ON, Canada 2020
    Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma Scorecard
  • Bioethics and Controversial Trends in Healthcare Innovation
    New York, NY, United States 2020
    Bioethics and Controversial Trends in Healthcare Innovation
  • Responsible Data Sharing in Medicine and Clinical Research
    Montreal, QC, Canada 2020
    Responsible Data Sharing in Medicine and Clinical Research
  • Non-Trial Preapproval Access to Investigational Medical Products
    New York, NY, United States 2020
    Non-Trial Preapproval Access to Investigational Medical Products
  • Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences Industry
    Coral Gables, FL, United States 2020
    Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences Industry
  • Oral Presentation
    Philadelphia, PA, United States 2020
    Oral Presentation
  • Global Health Justice and Access to Medicines
    Binghamton, NY, United States 2020
    Global Health Justice and Access to Medicines
  • Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical Industry
    Cambridge, MA, United States 2019
    Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical Industry
  • Ethics of Clinical Trials and Data Privacy
    Jerusalem, Jerusalem District, Israel 2019
    Ethics of Clinical Trials and Data Privacy
  • Access to Emerging Therapies for Genetic Disorders
    Rochester, NY, United States 2019
    Access to Emerging Therapies for Genetic Disorders
  • Responsible Clinical Trial Transparency and Data Sharing
    Philadelphia, PA, United States 2019
    Responsible Clinical Trial Transparency and Data Sharing
  • Responsible Data Sharing
    Philadelphia, PA, United States 2019
    Responsible Data Sharing
  • Brain Health and Performance Summit, Whose Data are They?
    Columbus, OH, United States 2019
    Brain Health and Performance Summit, Whose Data are They?
  • Inaugural Councils Meeting
    San Francisco, CA, United States 2019
    Inaugural Councils Meeting
  • Progress Towards the Sustainable Development Goals
    Princeton, NJ, United States 2019
    Progress Towards the Sustainable Development Goals
  • Ethics of Data-Sharing in Digital Medicine
    Boston, MA, United States 2019
    Ethics of Data-Sharing in Digital Medicine
  • Roundtable on Data-Sharing in Medicine
    Los Angeles, CA, United States 2019
    Roundtable on Data-Sharing in Medicine
  • Ethics of Big Data and AI in Radiology
    New York, NY, United States 2019
    Ethics of Big Data and AI in Radiology
  • Social Responsibility in Pharma
    Philadelphia, PA, United States 2019
    Social Responsibility in Pharma
  • Breaking Barriers to Health Data Governance
    San Francisco, CA, United States 2019
    Breaking Barriers to Health Data Governance
  • Ethics of Federated Models
    San Francisco, CA, United States 2019
    Ethics of Federated Models
  • Solutions Approach to Data Privacy and Ethics
    Washington, DC, United States 2019
    Solutions Approach to Data Privacy and Ethics
  • Establishing a Pharma Code of Ethics
    Barcelona, CT, Spain 2019
    Establishing a Pharma Code of Ethics
  • Preventing the Cambridge Analytica of Health Data
    Austin, TX, United States 2019
    Preventing the Cambridge Analytica of Health Data
  • Data-sharing Principles in Medicine
    Bethesda, MD, United States 2019
    Data-sharing Principles in Medicine
  • Ethics of Emerging Biotechnologies
    Dubai, Dubai, United Arab Emirates 2018
    Ethics of Emerging Biotechnologies
  • The Ethics of Big Data in Healthcare. October 24, 2018
    New York, NY, United States 2018
    Opening Keynote: The Ethics of Big Data in Healthcare. October 24, 2018
  • The Future of Health Summit, Panel on Innovation
    Los Angeles, CA, United States 2018
    The Future of Health Summit, Panel on Innovation
  • Measuring Impact in Patient-Centered Drug Development
    Bethesda, MD, United States 2018
    Measuring Impact in Patient-Centered Drug Development
  • Blockchain as Pharma's Trust Catalyst
    Madrid, Community of Madrid, Spain 2018
    Blockchain as Pharma's Trust Catalyst
  • Deconstructing Clinical Trials: The Core of Drug Development and Company Valuations
    London, England, United Kingdom 2018
    Deconstructing Clinical Trials: The Core of Drug Development and Company Valuations
  • Ethics and Trust in Healthcare Innovation
    New York, NY, United States 2018
    Keynote, Ethics and Trust in Healthcare Innovation
  • Research Ethics Workshop
    New York, NY, United States 2018
    Research Ethics Workshop
  • Promise and Reality of Clinical Trial Transparency and Data-sharing
    London, England, United Kingdom 2018
    Promise and Reality of Clinical Trial Transparency and Data-sharing
  • Ethics and Governance and Healthcare Innovation
    New York, NY, United States 2018
    Ethics and Governance and Healthcare Innovation
  • Clinical Trial Transparency and Data-sharing in Healthcare Innovation
    New York, NY, United States 2018
    Clinical Trial Transparency and Data-sharing in Healthcare Innovation
  • Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals Marketplace
    Baltimore, MD, United States 2018
    Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals Marketplace
  • Big Data and Ethics
    New York, NY, United States 2018
    Big Data and Ethics
  • Ethics of Big Data, Machine Learning and AI
    New York, NY, United States 2018
    Ethics of Big Data, Machine Learning and AI
  • Elevate Organizational and New Drug Clinical Trial Transparency Best Practices
    Philadelphia, PA, United States 2018
    Elevate Organizational and New Drug Clinical Trial Transparency Best Practices
  • Lecture on Pharmaceutical Ethics
    Augusta, GA, United States 2017
    Lecture on Pharmaceutical Ethics
  • Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma Scorecard
    Augusta, GA, United States 2017
    Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma Scorecard
  • Augmented Humans: Are Super Humans the New Reality?
    Dubai, Dubai, United Arab Emirates 2017
    Augmented Humans: Are Super Humans the New Reality?
  • Cybersecurity’s Accelerating Threat: The Impact of Evolving Technologies
    New York, NY, United States 2017
    Cybersecurity’s Accelerating Threat: The Impact of Evolving Technologies
  • Returning Lay Summaries to Trial Participants
    Philadelphia, PA, United States 2017
    Returning Lay Summaries to Trial Participants
  • Data-Sharing: Do We Measure Up?
    Rockville, MD, United States 2017
    Data-Sharing: Do We Measure Up?
  • The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?
    New York, NY, United States 2017
    The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?
  • Transparency in Healthcare
    Cambridge, MA, United States 2017
    Transparency in Healthcare
  • The Intersecting Worlds of Researchers, Executives and Journalists
    Greencastle, IN, United States 2017
    The Intersecting Worlds of Researchers, Executives and Journalists
  • Ethics and Trust in the Pharmaceutical Industry
    New York, NY, United States 2017
    Ethics and Trust in the Pharmaceutical Industry
  • Cyber Security
    New York, NY, United States 2017
    Cyber Security
  • Clinical Trial Transparency, Data-sharing, and the Good Pharma Scorecard
    New Brunswick, NJ, United States 2017
    Clinical Trial Transparency, Data-sharing, and the Good Pharma Scorecard
  • Healthcare Innovation Ethics
    New York, NY, United States 2017
    Healthcare Innovation Ethics
  • Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma Scorecard
    London, England, United Kingdom 2017
    Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma Scorecard
  • Access, Value, and Trust in Healthcare Innovation
    Newport Beach, CA, United States 2017
    Access, Value, and Trust in Healthcare Innovation
  • Clinical Trial Transparency, Drug Development, and the Good Pharma Scorecard
    New York, NY, United States 2016
    Clinical Trial Transparency, Drug Development, and the Good Pharma Scorecard
  • Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma Scorecard
    Basel, BS, Switzerland 2016
    Clinical Trial Transparency and Regulation Conference, Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma Scorecard
  • Ethics and Trust in Healthcare Innovation
    Palo Alto, CA, United States 2016
    Ethics and Trust in Healthcare Innovation
  • Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health Systems
    Newark, NJ, United States 2016
    Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health Systems
  • Working Together to Serve Patients
    New York, NY, United States 2016
    Working Together to Serve Patients
  • Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health Policy
    New York, NY, United States 2016
    Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health Policy
  • Ethics and Transparency in Healthcare Innovation
    Philadelphia, PA, United States 2016
    Ethics and Transparency in Healthcare Innovation
  • The Good Pharma Scorecard: Special Focus on Publications
    Tarrytown, NY, United States 2016
    The Good Pharma Scorecard: Special Focus on Publications
  • Ethical Issues in Clinical Research
    New York, NY, United States 2016
    Ethical Issues in Clinical Research
  • Pharmaceutical Strategy: Ethics and Reputational Hazards
    New York, NY, United States 2016
    Pharmaceutical Strategy: Ethics and Reputational Hazards
  • Ethics and Governance of Healthcare Innovation and the Good Pharma Scorecard
    New York, NY, United States 2016
    Ethics and Governance of Healthcare Innovation and the Good Pharma Scorecard
  • Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public Good
    New York, NY, United States 2016
    Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public Good
  • Institutional Corruption in Medicine and Healthcare Innovation: Concerns, Benchmarks, and a Roadmap for Trustworthy Reform
    Washington, DC, United States 2016
    Institutional Corruption and Medicine
  • Institutional Corruption and Medicine
    Chattanooga, TN, United States 2016
    Institutional Corruption and Medicine
  • Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
    New York, NY, United States 2015
    Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
  • Lecture
    New York, NY, United States 2015
    Lecture
  • Research Spotlight Presentation
    New York, NY, United States 2015
    Research Spotlight Presentation
  • Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?
    Baltimore, MD, United States 2015
    Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?
  • Transparency and Data Sharing Roundtable
    Cambridge, MA, United States 2015
    Transparency and Data Sharing Roundtable
  • Promises and Pitfalls of our Clinical Research System
    New York, NY, United States 2015
    Lecture
  • The Ethics of Healthcare Innovation
    New York, NY, United States 2015
    The Ethics of Healthcare Innovation
  • Lecture
    London, England, United Kingdom 2015
    Lecture
  • Lecture
    Binghamton, NY, United States 2015
    Lecture
  • Institutional Corruption in Medicine
    Cambridge, MA, United States 2015
    Institutional Corruption in Medicine
  • Research Ethics
    New York, NY, United States 2015
    Research Ethics
  • Ethics, Trust, Global Health and the Pharmaceutical Industry
    Cambridge, MA, United States 2015
    Ethics, Trust, Global Health and the Pharmaceutical Industry
  • Lecture
    Binghamton, NY, United States 2015
    Lecture
  • Bioethics and Trust in the Industry– Could Rating Help?
    Cambridge, MA, United States 2015
    Bioethics and Trust in the Industry– Could Rating Help?
  • Ethics, Trust, Global Health and the Pharmaceutical Industry
    Durham, NC, United States 2015
    Ethics, Trust, Global Health and the Pharmaceutical Industry
  • Shining Light on Healthcare Innovation
    Durham, NC, United States 2015
    Shining Light on Healthcare Innovation
  • Data-sharing in Clinical Trials
    Cambridge, MA, United States 2015
    Data-sharing in Clinical Trials
  • Combatting Institutional Corruption in Medicine with the Open Pharma Index
    Cambridge, MA, United States 2015
    Institutional Corruption in Medicine
  • Ethics, Human Rights and the Pharmaceutical Industry
    Durham, CT, United States 2015
    Ethics, Human Rights and Business
  • Transparency and Ethics in Healthcare Innovation
    Newark, NJ, United States 2015
    Transparency and Ethics in Healthcare Innovation
  • Compassionate Use and Pre-Approval Access to Experimental Drugs
    New York, NY, United States 2015
    Compassionate Use and Pre-Approval Access to Experimental Drugs
  • Ethics, Human Rights and the Pharmaceutical Industry
    Durham, NC, United States 2015
    Ethics, Human Rights and the Pharmaceutical Industry
  • Transparency and Ethics in Healthcare Innovation
    Newark, NJ, United States 2015
    Transparency and Ethics in Healthcare Innovation
  • Corruption, Ethics and Governance in Biomedical Research
    Durham, NC, United States 2014
    Corruption, Ethics and Governance in Biomedical Research
  • Adaptive Regulatory Strategies in Healthcare Innovation
    Durham, NC, United States 2014
    Adaptive Regulatory Strategies in Healthcare Innovation
  • Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?
    Cambridge, MA, United States 2014
    Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?
  • Ethics in the Pharmaceutical Industry: Could Rating Help?
    New York, NY, United States 2014
    Ethics in the Pharmaceutical Industry: Could Rating Help?
  • Bioethics and Trust in the Industry– Could Rating Help?
    Cambridge, MA, United States 2014
    Bioethics and Trust in the Industry– Could Rating Help?
  • Ethics and Trust in the Pharmaceutical Industry
    Mexico City, CDMX, Mexico 2014
    Ethics and Trust in the Pharmaceutical Industry
  • Truth-telling and the Pharmaceutical Industry
    New York, NY, United States 2014
    Truth-telling and the Pharmaceutical Industry
  • Institutional Corruption in Big Pharma
    Cambridge, MA, United States 2014
    Institutional Corruption in Big Pharma
  • Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy Reform
    Cambridge, MA, United States 2014
    Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy Reform
  • Ethical Standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy Reform
    Pittsburgh, PA, United States 2014
    Ethical standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy Reform
  • Companies’ Global Health Footprint: Could Rating Help?
    Cambridge, MA, United States 2013
    Companies’ Global Health Footprint: Could Rating Help?
  • Globalization and the Market
    New York, NY, United States 2013
    Globalization and the Market
  • Public Health Ethics
    Washington, DC, United States 2013
    Public Health Ethics
  • Bioethics and Trust in the Industry
    Cambridge, MA, United States 2013
    Bioethics and Trust in the Industry
  • Bioethics and Trust in the Industry
    Cambridge, MA, United States 2013
    Bioethics and Trust in the Industry
  • Ethical Standards in the Pharmaceutical Industry?
    New York, NY, United States 2013
    Ethical Standards in the Pharmaceutical Industry?
  • Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
    Amherst, MA, United States 2013
    Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
  • Blinding Science: Blinding as a Solution to Institutional Corruption
    Cambridge, MA, United States 2013
    Blinding Science: Blinding as a Solution to Institutional Corruption
  • Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
    Boston, MA, United States 2013
    Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
  • Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
    Boston, MA, United States 2013
    Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
  • Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform Strategies
    Cambridge, MA, United States 2012
    Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform Strategies
  • Pharmaceutical Ethics
    New York, NY, United States 2012
    Pharmaceutical Ethics
  • The Ethics of Drug Development and Marketing
    New York, NY, United States 2012
    The Ethics of Drug Development and Marketing
  • Ethical Standards for the Pharmaceutical Industry?
    Jersey City, NJ, United States 2012
    Ethical Standards for the Pharmaceutical Industry?
  • Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory Regimes
    New Orleans, LA, United States 2012
    Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory Regimes, January 14, 2012
  • The Role of Virtue in Medicine,
    Chicago, IL, United States 2011
    The Role of Virtue in Medicine,
  • Ethical Issues in Pediatric Emergency Mass Critical Care
    Bangkok, Bangkok, Thailand 2011
    Ethical Issues in Pediatric Emergency Mass Critical Care
  • Introduction to Bioethical Frameworks
    Bangkok, Bangkok, Thailand 2011
    Introduction to Bioethical Frameworks
  • Bioethical Issues in the Globalization of Clinical Research
    Albany, NY, United States 2011
    Bioethical Issues in the Globalization of Clinical Research
  • Pharmaceutical Ethics
    Durham, NC, United States 2011
    Pharmaceutical Ethics
  • Genomics, Ethics and Industry Practice
    Burnaby, BC, Canada 2011
    Genomics, Ethics and Industry Practice
  • Medical Diplomacy: Response to Environmental Disasters
    New York, NY, United States 2011
    Medical Diplomacy: Response to Environmental Disasters
  • Ethical Concerns in Biotechnology and Health Care Advances
    Washington, DC, United States 2011
    Ethical Concerns in Biotechnology and Health Care Advances
  • Next Steps for the Princeton University Open Hearts Initiative
    New Orleans, LA, United States 2011
    Next Steps for the Princeton University Open Hearts Initiative
  • Disaster Medicine
    New York, NY, United States 2010
    Disaster Medicine
  • 15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-Third Special Session of the General Assembly (2000)
    New York, NY, United States 2010
    15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-third Special Session of the General Assembly (2000)
  • Lecture
    Tampa, FL, United States 2010
    Lecture
  • Lecture
    Erie, PA, United States 2010
    Lecture
  • Finding Common Ground
    Princeton, NJ, United States 2010
    Debate
  • Is Common Ground Possible?
    Princeton, NJ, United States 2010
    Is Common Ground Possible?
  • Who Should be Responsible for Tomorrow’s Drugs?
    San Diego, CA, United States 2010
    Who Should be Responsible for Tomorrow’s Drugs?
  • Introduction to Ethical Frameworks and Clinical Decision-Making
    New York, NY, United States 2009
    Introduction to Ethical Frameworks and Clinical Decision-Making
  • Climate Change, Public Health and Emergency Preparedness,
    New York, NY, United States 2009
    Climate Change, Public Health and Emergency Preparedness,
  • Biotechnology in 20 Years: Privatization and Ethical Considerations
    New York, NY, United States 2008
    Biotechnology in 20 Years: Privatization and Ethical Considerations
  • Balancing Autonomy and Community in Promotion of Human Dignity
    New York, NY, United States 2008
    Balancing Autonomy and Community in Promotion of Human Dignity
  • New Dilemmas in Modern Medicine
    New York, NY, United States 2008
    New Dilemmas in Modern Medicine
  • Ethics of Pandemic Decision-making and Allocation of Medical Resources
    Erie, PA, United States 2008
    Ethics of Pandemic Decision-making and Allocation of Medical Resources
  • Ethical Frameworks and Disaster Preparedness
    Erie, PA, United States 2008
    Ethical Frameworks and Disaster Preparedness
  • New Ethical Dilemmas in Medicine
    New York, NY, United States 2008
    New Ethical Dilemmas in Medicine
  • Bioethical Frameworks and Pandemic Preparedness
    New York, NY, United States 2007
    Bioethical Frameworks and Pandemic Preparedness
  • Did I Hasten My Patient’s Death?
    Bridgeport, CT, United States 2007
    Did I Hasten My Patient’s Death?
  • Lecture
    Bridgeport, CT, United States 2007
    -
  • Lecture
    Bridgeport, CT, United States 2007
    Lecture
  • Grand Rounds Lecture
    Bridgeport, CT, United States 2007
    Grand Rounds Lecture
  • Ethics of Adoption and Freezing of Embryos and Natural Law
    New York, NY, United States 2005
    Ethics of Adoption and Freezing of Embryos and Natural Law
  • Stem Cell Research Ethics, Course Lecture for Philosophical Ethics
    New York, NY, United States 2002
    Stem Cell Research Ethics, Course Lecture for Philosophical Ethics

Honors & Recognition

AwardAwarding OrganizationDate
Center for the Fourth Industrial Revolution, Precision Medicine CouncilAppointment to World Economic Forum2019
Biotechnology CouncilAppointment to World Economic Forum2018
Futures CouncilAppointment to World Economic Forum2017
Human Enhancement Working GroupAppointment to World Economic Forum2017
Ethical Issues in Global Population Health, Foundation BrocherFellow2014
United Nations Educational Social and Cultural Organization (UNESCO) Global Ethics ObservatoryAppointed2009

Professional Service

OrganizationRoleDate
Present Working Group Member, Consortia for Improving Medicine with Innovation and Technology (CIMIT), Yale University (NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2) directed at Yale by Michael K. Dempsey & at Harvard by Steven SchachterNIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter2020
Yale Pediatric Nephrology Residents Research Ethics Lecture (March 27, 2020)Lecturer2020
Yale Data Day, Cushing Whitney Medical Library Class: "Data and Privacy: Day of Data Series Panel Discussion, Yale Medical School Library (February 13, 2020)Participant2020
Yale Center For Clinical Investigation (YCCI), NCATS Clinical Translational Science Award (CTSA), Mount Sinai Curriculum for Bioethics Training in Data Science and AILead2020 - Present
Present Yale Equity Research and Innovation Center (ERIC), Covid Disparities Working GroupMember2020 - Present
Consortia for Improving Medicine with Innovation and Technology (CIMIT), NIH-funded U54 Coordinating CenterNIH-funded U54 Coordinating Center focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter2020 - Present
Alexion Pharmaceuticals Ethics Committee, Expanded Access Program for Covid-Related Drugs and ALS ProgramCommittee Member2020 - Present
Scientific American, Science for GoodEditor2020 - Present
Expanded Access Program for Covid-Related Drugs and ALS Program, Ethics Committee, Alexion PharmaceuticalsCommittee Member2020 - Present
Committee on Standards for Data Collection and Use, IEEEAdvisor2019 - 2020
Yale Law School Health Data Workshop Co-Chair with Chris Morten, Joe Ross, Jen Pinsoff, Amy KapczynskiCo-Chair2019
Yale Digital Medicine Symposium, Ethical Considerations in Digital Medicine, April 26, 2019Presenter/Speaker2019
Nature MedicineReviewer2019 - Present
BMC MedicineReviewer2019 - Present
The Journal of BioethicsReviewer2019 - Present
Yale Law School, Center for Research and IntegrityMember2018 - 2019
Yale Law School MFIA Clinic, Data-Sharing in Medicine, SupervisorLead2018 - 2019
Director’s Working Group on Ethical Considerations for Industry Partnership on Research to Help End the Opioid Crisis, NIHCommittee Member2018
New England Journal of Medicine (NEJM)Reviewer2018 - Present
The British Medical Journal (BMJ)Reviewer2018 - Present
World Economic ForumMember2017 - Present
New York University (NYU) School of Medicine, Pharmacy and Therapeutics CommitteeCommittee Member2016 - 2019
The Journal of the American Medical Association (JAMA) Internal MedicineReviewer2016 - Present
Pharmacy and Therapeutics Committee, NYU School of MedicineCommittee Member2016 - Present
NYU Electronic Medical Records (EMR) Working Group, New York UniversityTasked with developing new guidelines for incorporating clinical research into Epic2016 - Present
Institutional Review Board, Embryonic Stem Cell Research Oversight, New York University (NYU) School of MedicineCommittee Member2015 - 2019
Compassionate Use and Expanded Access Committee, Johnson and Johnson (J&J) and New NYU School of MedicineScientific Advisor2015 - 2017
Journal of Evidence-based Medicine & Public HealthEditor2015 - 2016
Committee on Data Sharing and Transparency, Harvard University Multi-Regional Clinical Trials InitiativeBoard Member2015 - 2016
Advanced Disaster Life Support (ADLS®)Ethical and Legal Considerations (Chapter 5), Advanced Disaster Life Support (ADLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer)2015
Core Disaster Life Support (CDLS®)Legal and Ethical Issues (Chapter 5), Core Disaster Life Support (CDLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer)2015
Journal of Clinical PharmacologyReviewer2015 - Present
Stem Cells Translation MedicineReviewer2015 - Present
Embryonic Stem Cell Research Oversight Committee, NYU School of MedicineCommittee Member2015 - Present
Pragmatic Clinical Trials Initiative, Gatekeepers Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research NetworkBoard Member2014 - 2015
Pragmatic Clinical Trials Initiative, Vulnerable Subjects Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research NetworkBoard Member2014 - 2015
Public Library of Science (PLOS ONE)Reviewer2014 - Present
Criteria for Data Sharing Subgroup, Harvard University Multi-Regional Clinical Trials InitiativeCo-Chair2013 - 2014
Pharmaceutical Regulatory Affairs: Open Access, OMICS Publishing GroupReviewer2013 - Present
Law and Society Association, Institutional CorruptionCommittee Member2012 - 2015
Ethics Committee, Harvard University Multi-Regional Clinical Trials InitiativeCommittee Member2012 - 2014
American Society of Bioethics and HumanitiesMember2012 - Present
Center for Policy and Emerging Technologies, Advisory BoardBoard Member2010 - 2015
Center for Policy and Emerging Technologies, Center for Policy and Emerging TechnologiesAdvisor2010 - 2015
Advisory Board, Center for Policy and Emerging TechnologiesAdvisor2010 - 2015
Ethics Committee and IRB Workshop Director, Tampa General Hospital, Morsani College of Medicine, University of South FloridaDirector2010
Pediatric Emergency Mass Critical Care Taskforce, Steering Committee, Centers for Disease Control and Prevention (CDC)Committee Member2009 - 2011
Pediatric Emergency Mass Critical Care Taskforce, Ethics Committee, Centers for Disease Control and Prevention (CDC)Committee Member2009 - 2011
Pandemic and Emergency Preparedness Ethics Grand Rounds Director, St. Vincent’s Health System (Pennsylvania)Director2008
Pandemic and Emergency Preparedness Ethics Grand Rounds Director for the Department of Emergency Medicine, Hamot Hospital (Pennsylvania)Director2008
American Medical Association, National Disaster Life Support Education ConsortiumMember2007 - 2011
American Museum of Natural History, Junior Advisory CouncilCouncil Member2007 - 2011
ICU Rounds on End of Life Care Ethics, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Medical Ethics Lecturer for Radiology and Transitional Year Residency Program, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Medical Ethics Lecturer for Internal Medicine Department, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Pandemic and Emergency Preparedness Ethics Hospital-Wide Grand Rounds, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Bioethics InternationalPresident2006 - Present
Bioethics InternationalBoard Member2005 - Present
Bellevue Hospital, High School Pediatric Psychiatric Ward Volunteers, Volunteer DirectorDirector2004 - 2006

Departments & Organizations

Edit Profile